These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3435605)

  • 1. Biobusiness in the pharmaceutical industry.
    Werner RG
    Arzneimittelforschung; 1987 Sep; 37(9):1086-93. PubMed ID: 3435605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New biotechnology as a logical outgrowth of molecular biology.
    Werner RG
    Arzneimittelforschung; 1986 Sep; 36(9):1429-36. PubMed ID: 2431696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene technology: chances for diagnosis and therapy.
    Werner RG
    Methods Find Exp Clin Pharmacol; 1994 Sep; 16(7):525-37. PubMed ID: 7885080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Back to the future: biotech product sales 1983-1993.
    Klausner A
    Biotechnology (N Y); 1993 Mar; 11(3):S35-7. PubMed ID: 7763433
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotechnology in India.
    Ghosh PK
    Australas Biotechnol; 1993; 3(4):214-5, 218-22. PubMed ID: 7764132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotechnology and genetic engineering in the new drug development. Part I. DNA technology and recombinant proteins.
    Stryjewska A; Kiepura K; Librowski T; Lochyński S
    Pharmacol Rep; 2013; 65(5):1075-85. PubMed ID: 24399704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Russia through the prism of the world biopharmaceutical market.
    Bairamashvili DI; Rabinovich ML
    Biotechnol J; 2007 Jul; 2(7):801-17. PubMed ID: 17615600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges and opportunities in biotechnology.
    Overby LR
    Prog Clin Biol Res; 1985; 182():425-43. PubMed ID: 2994109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commercial development of microalgal biotechnology: from the test tube to the marketplace.
    Olaizola M
    Biomol Eng; 2003 Jul; 20(4-6):459-66. PubMed ID: 12919832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valuable products from biotechnology of microalgae.
    Pulz O; Gross W
    Appl Microbiol Biotechnol; 2004 Nov; 65(6):635-48. PubMed ID: 15300417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials of gene/biotechnology products.
    Röthig HJ
    Methods Find Exp Clin Pharmacol; 1994 Sep; 16(7):539-44. PubMed ID: 7885081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical biotechnology in India.
    Lohray BB
    Adv Biochem Eng Biotechnol; 2003; 85():215-81. PubMed ID: 12930097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specifications from a biotechnology industry perspective.
    Garnick RL
    Dev Biol Stand; 1997; 91():31-6. PubMed ID: 9413680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White biotechnology: ready to partner and invest in.
    Kircher M
    Biotechnol J; 2006; 1(7-8):787-94. PubMed ID: 16897821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug products of recombinant DNA technology.
    Black WJ
    Am J Hosp Pharm; 1989 Sep; 46(9):1834-44. PubMed ID: 2679063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotech drug market steadily expands.
    Lawrence S
    Nat Biotechnol; 2005 Dec; 23(12):1466. PubMed ID: 16333279
    [No Abstract]   [Full Text] [Related]  

  • 18. The biotechnology innovation machine: a source of intelligent biopharmaceuticals for the pharma industry--mapping biotechnology's success.
    Evens RP; Kaitin KI
    Clin Pharmacol Ther; 2014 May; 95(5):528-32. PubMed ID: 24448474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deconstructing Myogen's market cap.
    Ransom J
    Nat Biotechnol; 2006 Mar; 24(3):227-8. PubMed ID: 16525363
    [No Abstract]   [Full Text] [Related]  

  • 20. Private investment in AIDS vaccine development: obstacles and solutions.
    Batson A; Ainsworth M
    Bull World Health Organ; 2001; 79(8):721-7. PubMed ID: 11545328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.